Evidence map›Paper›PMID 29866045›Full record

ArticleBMC genomics2018

Landscape of transcriptional deregulation in lung cancer.

Shu Zhang, Mingfa Li, Hongbin Ji, Zhaoyuan Fang

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 44 citations in OpenAlex.

  1. Dual Effect ofBiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. mMedComm · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Shu ZhangSchool of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, People's Republic of China.
Mingfa LiSchool of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, People's Republic of China.
Hongbin JiState Key Laboratory of Cell Biology, Shanghai, China. hbji@sibcb.ac.cn.
Zhaoyuan FangState Key Laboratory of Cell Biology, Shanghai, China. fangzhaoyuan@sibs.ac.cn.ORCID http://orcid.org/0000-0002-0393-2052
Shanghai Jiao Tong University · CNShanghai Institutes for Biological Sciences · CNShanghaiTech University · CN

Funding

National Basic Research Program of China 2017YFA0505500National Natural Science Foundation of China 81430066, 91731314, 31621003National Natural Science Foundation of China 81602459Strategic Priority Research Program of the Chinese Academy of Sciences XDB19000000
6 · The paper itself

Abstract

backgroundLung cancer is a very heterogeneous disease that can be pathologically classified into different subtypes including small-cell lung carcinoma (SCLC), lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC) and large-cell carcinoma (LCC). Although much progress has been made towards the oncogenic mechanism of each subtype, transcriptional circuits mediating the upstream signaling pathways and downstream functional consequences remain to be systematically studied.

resultsHere we trained a one-class support vector machine (OC-SVM) model to establish a general transcription factor (TF) regulatory network containing 325 TFs and 18724 target genes. We then applied this network to lung cancer subtypes and identified those deregulated TFs and downstream targets. We found that the TP63/SOX2/DMRT3 module was specific to LUSC, corresponding to squamous epithelial differentiation and/or survival. Moreover, the LEF1/MSC module was specifically activated in LUAD and likely to confer epithelial-to-mesenchymal transition, known important for cancer malignant progression and metastasis. The proneural factor, ASCL1, was specifically up-regulated in SCLC which is known to have a neuroendocrine phenotype. Also, ID2 was differentially regulated between SCLC and LUSC, with its up-regulation in SCLC linking to energy supply for fast mitosis and its down-regulation in LUSC linking to the attenuation of immune response. We further described the landscape of TF regulation among the three major subtypes of lung cancer, highlighting their functional commonalities and specificities.

conclusionsOur approach uncovered the landscape of transcriptional deregulation in lung cancer, and provided a useful resource of TF regulatory network for future studies.

Indexed as

Gene Expression Regulation, NeoplasticTranscription, GeneticGene Regulatory NetworksHumansLung NeoplasmsSOXB1 Transcription FactorsTranscription FactorsTumor Suppressor ProteinsDmrt3 protein, mouseSOXB1 Transcription FactorsTP63 protein, humanTranscription FactorsTumor Suppressor ProteinsLung cancerSupport-vector machinesTranscription factorsTranscription regulatory network

Identifiers

PMID29866045
PMCPMC5987572
OpenAlexW2805214175

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.